Latest Insider Transactions at Comera Life Sciences Holdings, Inc. (CMRA)
This section provides a real-time view of insider transactions for Comera Life Sciences Holdings, Inc. (CMRA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Comera Life Sciences Holdings, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Comera Life Sciences Holdings, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 27
2023
|
Michael Gerard Campbell EVP & CFO |
BUY
Open market or private purchase
|
Direct |
10,000
+22.22%
|
$0
$0.07 P/Share
|
|
Nov 15
2023
|
William A. Wexler Director |
BUY
Other acquisition or disposition
|
Direct |
3,113
+13.01%
|
-
|
|
Sep 11
2023
|
David Soane > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
117,360
+17.11%
|
$0
$0.51 P/Share
|
|
Sep 11
2023
|
Charles Cherington > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
2,053,789
+26.1%
|
$0
$0.51 P/Share
|
|
Aug 14
2023
|
Robert Patrick Mahoney Chief Scientific Officer |
BUY
Open market or private purchase
|
Direct |
20,000
+13.83%
|
$0
$0.63 P/Share
|
|
Aug 11
2023
|
William A. Wexler Director |
BUY
Other acquisition or disposition
|
Direct |
6,636
+27.27%
|
-
|
|
Jul 31
2023
|
Charles Cherington > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
880,195
+18.97%
|
$0
$0.51 P/Share
|
|
Jul 31
2023
|
David Soane > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
273,838
+37.76%
|
$0
$0.51 P/Share
|
|
Jan 04
2023
|
Charles Cherington > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
743,243
+20.52%
|
$743,243
$1.23 P/Share
|
|
Jan 04
2023
|
Kirsten Flowers Director |
BUY
Grant, award, or other acquisition
|
Direct |
13,513
+37.84%
|
$13,513
$1.23 P/Share
|
|
Jan 04
2023
|
Edward Aloysius Sullivan Jr. Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,979
+35.83%
|
$10,979
$1.23 P/Share
|
|
Jan 04
2023
|
Stuart A Randle Director |
BUY
Grant, award, or other acquisition
|
Direct |
33,783
+44.3%
|
$33,783
$1.23 P/Share
|
|
Jan 04
2023
|
James Sherblom Director |
BUY
Grant, award, or other acquisition
|
Direct |
81,081
+15.2%
|
$81,081
$1.23 P/Share
|
|
Jan 04
2023
|
Barbara K Finck Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,756
+22.68%
|
$6,756
$1.23 P/Share
|
|
Jan 04
2023
|
Sirshendu Roopom Banerjee Director |
BUY
Grant, award, or other acquisition
|
Direct |
20,270
+41.18%
|
$20,270
$1.23 P/Share
|
|
Jan 04
2023
|
David Soane > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
202,701
+29.48%
|
$202,701
$1.23 P/Share
|
|
Nov 08
2022
|
David Soane > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
3,000
+0.09%
|
$3,000
$1.38 P/Share
|
|
Oct 21
2022
|
Charles Cherington > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
11,691
+1.77%
|
$11,691
$1.59 P/Share
|
|
Oct 20
2022
|
Charles Cherington > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
3,316
+0.52%
|
$3,316
$1.52 P/Share
|
|
Oct 17
2022
|
Charles Cherington > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
15,266
+2.35%
|
$15,266
$1.66 P/Share
|
|
Oct 14
2022
|
Charles Cherington > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
4,253
+0.68%
|
$4,253
$1.6 P/Share
|
|
Oct 13
2022
|
Charles Cherington > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
10,481
+1.67%
|
$10,481
$1.66 P/Share
|
|
Sep 29
2022
|
Charles Cherington > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
17,900
+2.87%
|
$17,900
$1.87 P/Share
|
|
Sep 27
2022
|
Charles Cherington > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
12,000
+2.0%
|
$12,000
$1.69 P/Share
|
|
Sep 12
2022
|
James Sherblom Director |
BUY
Open market or private purchase
|
Direct |
50,000
+11.87%
|
$100,000
$2.03 P/Share
|
|
Sep 09
2022
|
Jeffrey S. Hackman Director |
BUY
Open market or private purchase
|
Direct |
47,600
+50.0%
|
$95,200
$2.06 P/Share
|
|
Sep 08
2022
|
Michael Gerard Campbell EVP & CFO |
BUY
Open market or private purchase
|
Direct |
25,000
+50.0%
|
$50,000
$2.07 P/Share
|